With the support of the Foundation for Assistance to Small Innovative Enterprises, the Ministry of Industry and Trade of the Russian Federation and the Ministry of Education and Science of the Russian Federation, the following startups were launched to develop innovative medicines on the basis of the ChemRar High-Tech Center:

Aviron, Avivir — innovative targeted antivirals development projects for the treatment of hepatitis C, influenza and ARVI;

Avineuro — an original drug development project for the treatment of CNS diseases;

CardioSystemPharma — an original drug development project for the treatment of cardiovascular diseases;

Viriom — a project for the development of innovative antiviral drugs and combinations, as well as methods of treatment and diagnosis;

SatRx — a project for promising novel drug development for the treatment of type 2 diabetes and metabolic syndrome;

TeaRx — a drug development project for the prevention and treatment of thrombosis and thromboembolism